The 10 Most Promising New Drugs

BusinessWeek has selected ten of the most promising drugs to be launched over the next ten years based on Standard & Poor’s ratings. They are Amgen’s Denosumab (Osteoporosis), AstraZeneca’s Brilinta (Arterial Thrombosis), AstraZeneca/Bristol-Myers Squibb’s Onglyza (Diabetes), Bristol-Myers Squibb’s Belatacept (Organ Transplants), Lilly’s Effient (Platelet Inhibitor), King’s Embeda/Remoxy (Pain), Merck’s Cordaptive (Atherosclerosis), Novartis’ Afinitor (Oncology), Novo Nordisk’s [...]

Recession-Resistant Medicine

From the MIT’s Technology Review: In the third quarter of 2008, the first tremors of the financial crisis had been felt, and the number of venture deals in the U.S. fell to its lowest total since early 2005. According to Dow Jones’s VentureWire, which tracks venture investment, information technology companies fared particularly badly, with their [...]